OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Blood-Based Biomarkers for Alzheimer’s Disease Diagnosis and Progression: An Overview
Angelica Varesi, Adelaide Carrara, Vitor Gomes Pires, et al.
Cells (2022) Vol. 11, Iss. 8, pp. 1367-1367
Open Access | Times Cited: 76
Angelica Varesi, Adelaide Carrara, Vitor Gomes Pires, et al.
Cells (2022) Vol. 11, Iss. 8, pp. 1367-1367
Open Access | Times Cited: 76
Showing 1-25 of 76 citing articles:
The Bio‐Hermes Study: Biomarker database developed to investigate blood‐based and digital biomarkers in community‐based, diverse populations clinically screened for Alzheimer's disease
Richard C. Mohs, Douglas W. Beauregard, John Dwyer, et al.
Alzheimer s & Dementia (2024) Vol. 20, Iss. 4, pp. 2752-2765
Open Access | Times Cited: 20
Richard C. Mohs, Douglas W. Beauregard, John Dwyer, et al.
Alzheimer s & Dementia (2024) Vol. 20, Iss. 4, pp. 2752-2765
Open Access | Times Cited: 20
Gut-brain axis through the lens of gut microbiota and their relationships with Alzheimer's disease pathology: Review and recommendations
L. Krishaa, Ted Kheng Siang Ng, Hai Ning Wee, et al.
Mechanisms of Ageing and Development (2023) Vol. 211, pp. 111787-111787
Open Access | Times Cited: 30
L. Krishaa, Ted Kheng Siang Ng, Hai Ning Wee, et al.
Mechanisms of Ageing and Development (2023) Vol. 211, pp. 111787-111787
Open Access | Times Cited: 30
Sensitive label-free detection of the biomarker phosphorylated tau−217 protein in Alzheimer's disease using a graphene-based solution-gated field effect transistor
Sian-Hong Ciou, Ao-Ho Hsieh, Yu-Xiu Lin, et al.
Biosensors and Bioelectronics (2023) Vol. 228, pp. 115174-115174
Closed Access | Times Cited: 24
Sian-Hong Ciou, Ao-Ho Hsieh, Yu-Xiu Lin, et al.
Biosensors and Bioelectronics (2023) Vol. 228, pp. 115174-115174
Closed Access | Times Cited: 24
Amyloid-β and Phosphorylated Tau are the Key Biomarkers and Predictors of Alzheimer’s Disease
Jangampalli Adi Pradeepkiran, Javaria Baig, Md Ariful Islam, et al.
Aging and Disease (2024)
Open Access | Times Cited: 14
Jangampalli Adi Pradeepkiran, Javaria Baig, Md Ariful Islam, et al.
Aging and Disease (2024)
Open Access | Times Cited: 14
Pathogenesis, Diagnostics, and Therapeutics for Alzheimer's Disease: Breaking the Memory Barrier
Pushpa Tryphena Kamatham, Rashi K. Shukla, Dharmendra Kumar Khatri, et al.
Ageing Research Reviews (2024) Vol. 101, pp. 102481-102481
Open Access | Times Cited: 14
Pushpa Tryphena Kamatham, Rashi K. Shukla, Dharmendra Kumar Khatri, et al.
Ageing Research Reviews (2024) Vol. 101, pp. 102481-102481
Open Access | Times Cited: 14
Mechanisms and early efficacy data of caloric restriction and caloric restriction mimetics in neurodegenerative disease
Anchal Trisal, Abhishek Kumar Singh
Neuroscience (2025) Vol. 567, pp. 235-248
Closed Access | Times Cited: 1
Anchal Trisal, Abhishek Kumar Singh
Neuroscience (2025) Vol. 567, pp. 235-248
Closed Access | Times Cited: 1
Effect of the Lipid Landscape on the Efficacy of Cell-Penetrating Peptides
Florina Zákány, István M. Mándity, Zoltán Varga, et al.
Cells (2023) Vol. 12, Iss. 13, pp. 1700-1700
Open Access | Times Cited: 18
Florina Zákány, István M. Mándity, Zoltán Varga, et al.
Cells (2023) Vol. 12, Iss. 13, pp. 1700-1700
Open Access | Times Cited: 18
Aerobic exercise suppresses cognitive injury in patients with Alzheimer’s disease by regulating long non-coding RNA TUG1
Jiaojiao Chen, Caixia Su, Zhezhe Ma, et al.
Neuroscience Letters (2024) Vol. 826, pp. 137732-137732
Closed Access | Times Cited: 6
Jiaojiao Chen, Caixia Su, Zhezhe Ma, et al.
Neuroscience Letters (2024) Vol. 826, pp. 137732-137732
Closed Access | Times Cited: 6
Epigenetic Peripheral Biomarkers for Early Diagnosis of Alzheimer’s Disease
Chiara Villa, Andrea Stoccoro
Genes (2022) Vol. 13, Iss. 8, pp. 1308-1308
Open Access | Times Cited: 25
Chiara Villa, Andrea Stoccoro
Genes (2022) Vol. 13, Iss. 8, pp. 1308-1308
Open Access | Times Cited: 25
The potential of the gut microbiome for identifying Alzheimer’s disease diagnostic biomarkers and future therapies
Yu Zhan, Murad Al‐Nusaif, Cong Ding, et al.
Frontiers in Neuroscience (2023) Vol. 17
Open Access | Times Cited: 15
Yu Zhan, Murad Al‐Nusaif, Cong Ding, et al.
Frontiers in Neuroscience (2023) Vol. 17
Open Access | Times Cited: 15
Biomarkers in Alzheimer’s disease
Kayalvizhi Rajendran, Uma Maheswari Krishnan
Clinica Chimica Acta (2024) Vol. 562, pp. 119857-119857
Closed Access | Times Cited: 5
Kayalvizhi Rajendran, Uma Maheswari Krishnan
Clinica Chimica Acta (2024) Vol. 562, pp. 119857-119857
Closed Access | Times Cited: 5
Neurovascular unit, neuroinflammation and neurodegeneration markers in brain disorders
Duraisamy Kempuraj, Kirk D. Dourvetakis, Jessica R. Cohen, et al.
Frontiers in Cellular Neuroscience (2024) Vol. 18
Open Access | Times Cited: 5
Duraisamy Kempuraj, Kirk D. Dourvetakis, Jessica R. Cohen, et al.
Frontiers in Cellular Neuroscience (2024) Vol. 18
Open Access | Times Cited: 5
Acute Oncologic Complications: Clinical–Therapeutic Management in Critical Care and Emergency Departments
Nicole Gri, Yaroslava Longhitano, Christian Zanza, et al.
Current Oncology (2023) Vol. 30, Iss. 8, pp. 7315-7334
Open Access | Times Cited: 12
Nicole Gri, Yaroslava Longhitano, Christian Zanza, et al.
Current Oncology (2023) Vol. 30, Iss. 8, pp. 7315-7334
Open Access | Times Cited: 12
Central and Peripheral Inflammation in Mild Cognitive Impairment in the Context of Alzheimer’s Disease
Inès Schmidt-Morgenroth, Philippe Michaud, F. Gasparini, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 13, pp. 10523-10523
Open Access | Times Cited: 11
Inès Schmidt-Morgenroth, Philippe Michaud, F. Gasparini, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 13, pp. 10523-10523
Open Access | Times Cited: 11
Predicting clinical progression trajectories of early Alzheimer's disease patients
Viswanath Devanarayan, Yuanqing Ye, Arnaud Charil, et al.
Alzheimer s & Dementia (2023) Vol. 20, Iss. 3, pp. 1725-1738
Open Access | Times Cited: 11
Viswanath Devanarayan, Yuanqing Ye, Arnaud Charil, et al.
Alzheimer s & Dementia (2023) Vol. 20, Iss. 3, pp. 1725-1738
Open Access | Times Cited: 11
Mechanistic Approach to Immunity and Immunotherapy of Alzheimer’s Disease: A Review
Md. Rubiath Islam, Md. Afser Rabbi, Tanbir Hossain, et al.
ACS Chemical Neuroscience (2024)
Closed Access | Times Cited: 4
Md. Rubiath Islam, Md. Afser Rabbi, Tanbir Hossain, et al.
ACS Chemical Neuroscience (2024)
Closed Access | Times Cited: 4
A Multi-Label Deep Learning Model for Detailed Classification of Alzheimer's Disease
Mei Yang, Yuanzhi Zhao, Haihang Yu, et al.
Actas Españolas de Psiquiatría (2025) Vol. 53, Iss. 1, pp. 89-99
Open Access
Mei Yang, Yuanzhi Zhao, Haihang Yu, et al.
Actas Españolas de Psiquiatría (2025) Vol. 53, Iss. 1, pp. 89-99
Open Access
Biomarker Discovery and Phytochemical Interventions in Alzheimer's Disease: A Path to Therapeutic Advances
Mithila Debnath, Mahir Azmal, Rashid Taqui, et al.
Phytomedicine Plus (2025), pp. 100752-100752
Open Access
Mithila Debnath, Mahir Azmal, Rashid Taqui, et al.
Phytomedicine Plus (2025), pp. 100752-100752
Open Access
Targeted drug delivery in neurodegenerative diseases: the role of nanotechnology
Rupal Dhariwal, Mukul Jain, Y. Mir, et al.
Frontiers in Medicine (2025) Vol. 12
Open Access
Rupal Dhariwal, Mukul Jain, Y. Mir, et al.
Frontiers in Medicine (2025) Vol. 12
Open Access
Identification of Blood Plasma Protein Ratios for Distinguishing Alzheimer's Disease from Healthy Controls Using Machine Learning
Ali Safi, Elisa Giunti, Omar Melikechi, et al.
Heliyon (2025), pp. e42349-e42349
Open Access
Ali Safi, Elisa Giunti, Omar Melikechi, et al.
Heliyon (2025), pp. e42349-e42349
Open Access
Clinical biomarkers of perioperative neurocognitive disorder: initiation and recommendation
Jianhui Liu, Cheng Li, Junyan Yao, et al.
Science China Life Sciences (2025)
Closed Access
Jianhui Liu, Cheng Li, Junyan Yao, et al.
Science China Life Sciences (2025)
Closed Access
Emerging Role of Mesenchymal Stromal Cell and Exosome Therapies in Treating Cognitive Impairment
Vick Key Tew, Muttiah Barathan, Fazlina Nordin, et al.
Pharmaceutics (2025) Vol. 17, Iss. 3, pp. 284-284
Open Access
Vick Key Tew, Muttiah Barathan, Fazlina Nordin, et al.
Pharmaceutics (2025) Vol. 17, Iss. 3, pp. 284-284
Open Access
Integrating NLP and LLMs to discover biomarkers and mechanisms in Alzheimer's disease
Jin‐Won Song, Junjie Huang, Richen Liu
SLAS TECHNOLOGY (2025), pp. 100257-100257
Open Access
Jin‐Won Song, Junjie Huang, Richen Liu
SLAS TECHNOLOGY (2025), pp. 100257-100257
Open Access
The role of neuroimaging in Alzheimer’s disease: implications for the diagnosis, monitoring disease progression, and treatment
Julius Mulumba, Rui Duan, Bo Luo, et al.
Exploration of neuroscience (2025) Vol. 4
Open Access
Julius Mulumba, Rui Duan, Bo Luo, et al.
Exploration of neuroscience (2025) Vol. 4
Open Access
Pharmacological potential of calorie restriction mimetics in mitigating brain aging
Varsha Pai, Ishika Singh, Abhishek Kumar Singh
Advances in pharmacology (2025)
Closed Access
Varsha Pai, Ishika Singh, Abhishek Kumar Singh
Advances in pharmacology (2025)
Closed Access
